| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.7M | -21.4% |
| Cost of Revenue | $28.4M | +3.0% |
| Gross Profit | $21.3M | -40.2% |
| R&D Expense | $2.3M | -21.3% |
| SG&A Expense | $53.2M | -29.6% |
| Operating Income | -$32.0M | +21.2% |
| Pre-tax Income | -$29.8M | -28.1% |
| Income Tax | $39K | -92.6% |
| Net Income | -$29.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.6M | -52.7% |
| Accounts Receivable | $1.3M | -35.2% |
| Inventory | $18.9M | -12.2% |
| Current Assets | $47.0M | -39.9% |
| Total Assets | $113.4M | -25.6% |
| Current Liabilities | $15.9M | -32.6% |
| Total Liabilities | $86.4M | -11.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | -38.2% |
| Investing Cash Flow | -$3.8M | -8.3% |
| Financing Cash Flow | -$145K | +42.2% |
| -25.4% |
| EPS (Basic) | -$0.19 | -18.8% |
| EPS (Diluted) | -$0.19 | -18.8% |
| Stockholders' Equity |
| $27.1M |
| -51.2% |